Weiner LM - Search Results

1

Redirected cellular cytotoxicity employing bispecific antibodies and other multifunctional binding proteins.

Weiner LM, Alpaugh RK, von Mehren M. Weiner LM, et al. Cancer Immunol Immunother. 1997 Nov-Dec;45(3-4):190-2. doi: 10.1007/s002620050430. Cancer Immunol Immunother. 1997. PMID: 9435871 Free PMC article. Clinical Trial.

2

Antitumor effects of a bispecific antibody targeting CA19-9 antigen and CD16.

Garcia de Palazzo I, Holmes M, Gercel-Taylor C, Weiner LM. Garcia de Palazzo I, et al. Among authors: weiner lm. Cancer Res. 1992 Oct 15;52(20):5713-9. Cancer Res. 1992. PMID: 1394194

3

Bispecific monoclonal antibody regulation of Fc gamma RIII-directed tumor cytotoxicity by large granular lymphocytes.

de Palazzo IG, Kitson J, Gercel-Taylor C, Adams S, Weiner LM. de Palazzo IG, et al. Among authors: weiner lm. Cell Immunol. 1992 Jul;142(2):338-47. doi: 10.1016/0008-8749(92)90295-z. Cell Immunol. 1992. PMID: 1535829

4

Potentiation of tumor lysis by a bispecific antibody that binds to CA19-9 antigen and the Fc gamma receptor expressed by human large granular lymphocytes.

de Palazzo IG, Gercel-Taylor C, Kitson J, Weiner LM. de Palazzo IG, et al. Among authors: weiner lm. Cancer Res. 1990 Nov 15;50(22):7123-8. Cancer Res. 1990. PMID: 2146012

5

Phase I trial of 2B1, a bispecific monoclonal antibody targeting c-erbB-2 and Fc gamma RIII.

Weiner LM, Clark JI, Davey M, Li WS, Garcia de Palazzo I, Ring DB, Alpaugh RK. Weiner LM, et al. Cancer Res. 1995 Oct 15;55(20):4586-93. Cancer Res. 1995. PMID: 7553634 Clinical Trial.

6

Optimization of in vivo tumor targeting in SCID mice with divalent forms of 741F8 anti-c-erbB-2 single-chain Fv: effects of dose escalation and repeated i.v. administration.

Adams GP, McCartney JE, Wolf EJ, Eisenberg J, Tai MS, Huston JS, Stafford WF 3rd, Bookman MA, Houston LL, Weiner LM. Adams GP, et al. Among authors: weiner lm. Cancer Immunol Immunother. 1995 May;40(5):299-306. doi: 10.1007/BF01519629. Cancer Immunol Immunother. 1995. PMID: 7600561 Free PMC article.

7

Highly specific in vivo tumor targeting by monovalent and divalent forms of 741F8 anti-c-erbB-2 single-chain Fv.

Adams GP, McCartney JE, Tai MS, Oppermann H, Huston JS, Stafford WF 3rd, Bookman MA, Fand I, Houston LL, Weiner LM. Adams GP, et al. Among authors: weiner lm. Cancer Res. 1993 Sep 1;53(17):4026-34. Cancer Res. 1993. PMID: 7689421

8

CD16+ monocytes in patients with cancer: spontaneous elevation and pharmacologic induction by recombinant human macrophage colony-stimulating factor.

Saleh MN, Goldman SJ, LoBuglio AF, Beall AC, Sabio H, McCord MC, Minasian L, Alpaugh RK, Weiner LM, Munn DH. Saleh MN, et al. Among authors: weiner lm. Blood. 1995 May 15;85(10):2910-7. Blood. 1995. PMID: 7742551 Free article. Clinical Trial.

9

Immunohistochemical detection of c-erbB-2 expression by neoplastic human tissue using monospecific and bispecific monoclonal antibodies.

Garcia de Palazzo I, Klein-Szanto A, Weiner LM. Garcia de Palazzo I, et al. Among authors: weiner lm. Int J Biol Markers. 1993 Oct-Dec;8(4):233-9. doi: 10.1177/172460089300800406. Int J Biol Markers. 1993. PMID: 7908024

10

Phase I trial of recombinant macrophage colony-stimulating factor and recombinant gamma-interferon: toxicity, monocytosis, and clinical effects.

Weiner LM, Li W, Holmes M, Catalano RB, Dovnarsky M, Padavic K, Alpaugh RK. Weiner LM, et al. Cancer Res. 1994 Aug 1;54(15):4084-90. Cancer Res. 1994. PMID: 8033141 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

303 results

Search Page

Filters